首页> 外文期刊>The American surgeon. >Transanal Minimally Invasive Surgery (TAMIS): New Treatment for Early Rectal Cancer and Large Rectal Polyps-Experience of an Italian Center
【24h】

Transanal Minimally Invasive Surgery (TAMIS): New Treatment for Early Rectal Cancer and Large Rectal Polyps-Experience of an Italian Center

机译:经肛门微创手术(TAMIS):早期直肠癌和大直肠息肉的新疗法-意大利中心的经验

获取原文
获取原文并翻译 | 示例
           

摘要

Transanal endoscopic microsurgery (TEM) is a minimally invasive technique for excision of rectal tumors that avoids conventional pelvic resectional surgery along with its risks and side effects. Although appealing, the associated cost and complex learning curve limit TEM use by colorectal surgeons. Transanal minimally invasive surgery (TAMIS) has emerged as an alternative to TEM. This platform uses ordinary laparoscopic instruments to achieve high-quality local excision. The aim of the study is to assess reliability of the technique. From July 2012 to August 2013,15 consecutive patients with rectal pathology underwent TAMIS. After a single-incision laparoscopic surgery port was introduced into the anal canal, a pneumorectum was established with a laparoscopic device followed by transanal excision with conventional laparoscopic instruments, including graspers, electrocautery, and needle drivers. Patient demographics, operative data, and pathologic data were recorded. Of the 15 patients, 10 had rectal cancers (six T1 lesions and four T2 after preoperative chemoradiotherapy). The remainder of patients had a local excision for voluminous benign rectal adenomas. The median length of the lesions from the anal verge was 7 cm (range, 4 to 20 cm). The median operating time was 86 minutes (range, 33 to 160 minutes). There was no surgical morbidity or mortality. The median postoperative hospital stay was two days (range, 1 to 4 days). TAMIS seems to be a feasible and safe treatment option for early rectal cancer. We believe that this new technique is easy to perform, cost-effective, and less traumatic to the anal sphincter compared with traditional TEM.
机译:经肛门内窥镜显微外科手术(TEM)是一种用于切除直肠肿瘤的微创技术,可避免常规的盆腔切除术及其风险和副作用。尽管吸引人,但相关的成本和复杂的学习曲线限制了结直肠外科医师对TEM的使用。经肛门微创手术(TAMIS)已经成为TEM的替代方法。该平台使用普通的腹腔镜器械来实现高质量的局部切除。该研究的目的是评估该技术的可靠性。从2012年7月至2013年8月,连续15例直肠病理学患者接受了TAMIS。将单切口腹腔镜手术口引入肛管后,先用腹腔镜装置建立肺脏肿瘤,然后用常规腹腔镜仪器经肛门切除,包括抓紧器,电灼和针头驱动器。记录患者的人口统计学,手术数据和病理数据。在15例患者中,有10例患有直肠癌(术前放化疗后有6个T1病变和4个T2)。其余患者局部切除了大量的良性直肠腺瘤。肛门边缘病变的中位长度为7厘米(范围为4至20厘米)。中位操作时间为86分钟(范围为33至160分钟)。没有手术发病率或死亡率。术后中位住院时间为两天(范围为1至4天)。 TAMIS似乎是早期直肠癌的一种可行且安全的治疗选择。我们认为,与传统的TEM相比,这项新技术易于执行,具有成本效益并且对肛门括约肌的伤害较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号